Controversies in neurological infectious diseases.
The past several years have seen major advances in our understanding of neurological infectious diseases, their diagnosis, and their treatment. Along with these advances, however, new information about infectious agents and new therapeutic options have also introduced both uncertainty and controversy in the approach and management of patients with diseases of the central nervous system. Here, we discuss six such areas: the long-term efficacy of HAART therapy in treatment of HIV infection; the role of viral infection in chronic fatigue syndrome; Rasmussen's encephalitis as an infectious or autoimmune disease; the spectrum of neurological diseases caused by rickettsial infection; the role of Mycoplasma pneumoniae in human central nervous system disease; and the possible association of Chlamydia pneumoniae and human herpesvirus 6 with multiple sclerosis.
Greenlee
J E
JE
Neurology Service, Veterans Affairs Medical Center and Department of Neurology, University of Utah Health Science Center, Salt Lake City 84148-001, USA.
Rose
J W
JW
D015526:AIDS Dementia Complex / Q000188:drug therapy; D002494:Central Nervous System Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D016993:Chlamydophila pneumoniae / Q000472:pathogenicity / Q000502:physiology; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000276:immunology / Q000382:microbiology; D015673:Fatigue Syndrome, Chronic / Q000821:virology; D015654:Herpesvirus 6, Human / Q000472:pathogenicity / Q000502:physiology; D006801:Humans; D009103:Multiple Sclerosis / Q000821:virology; D009175:Mycoplasma Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D009177:Mycoplasma pneumoniae / Q000472:pathogenicity; D012282:Rickettsia Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology